Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Oct-24 4:06 PM View:  | Alnylam Pharmaceuticals Inc. (ALNY) | 08-Oct-24 | Grant | 96 | -- | -- | < 1% 16.29K to 16.39K | |
| 26-Jun-24 4:28 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jun-24 | Sale | 2,103 | $230.99 | $485,773.00 | (11%) 18.39K to 16.29K | |
| 26-Jun-24 4:28 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 24-Jun-24 | Grant | 4,295 | -- | -- | 30% 14.1K to 18.39K | |
| 05-Mar-24 4:21 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Mar-24 | Grant | 4,751 | -- | -- | 51% 9.35K to 14.1K | |
| 29-Feb-24 4:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Feb-24 | Option Sale | 574 | $155.30 | $89,144.60 | (6%) 9.92K to 9.35K | |
| 29-Feb-24 4:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Feb-24 | Option Exercise | 1,908 | -- | -- | 24% 8.01K to 9.92K | |
| 20-Feb-24 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Feb-24 | Sale | 1,308 | $148.06 | $193,666.00 | (14%) 9.32K to 8.01K | |
| 20-Feb-24 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Feb-24 | Grant | 4,295 | -- | -- | 85% 5.03K to 9.32K | |
| 07-Aug-23 6:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Aug-23 | Sale (Planned) | 4,166 | $183.89 | $766,083.00 | (45%) 9.19K to 5.03K | |
| 07-Aug-23 6:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-23 | Sale | 3,461 | $185.85 | $643,223.00 | (27%) 12.65K to 9.19K | |
| 07-Aug-23 6:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Grant | 7,627 | -- | -- | 152% 5.03K to 12.65K | |
| 28-Apr-23 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Apr-23 | Sale (Planned) | 2,455 | $199.02 | $488,595.00 | (33%) 7.48K to 5.03K | |
| 28-Apr-23 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 1,839 | $194.59 | $357,855.00 | (20%) 9.32K to 7.48K | |
| 28-Apr-23 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 4,294 | -- | -- | 85% 5.03K to 9.32K | |
| 07-Mar-23 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Mar-23 | Option Exercise | 5,000 | $96.45 | $482,250.00 | 28% 18.1K to 23.1K | |
| 07-Mar-23 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Mar-23 | Planned Option Sale | 5,000 | $200.00 | $1,000,000.00 | (22%) 23.1K to 18.1K | |
| 07-Mar-23 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Mar-23 | Sale (Planned) | 13,072 | $200.00 | $2,614,400.00 | (72%) 18.1K to 5.03K | |
| 05-Aug-22 4:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-22 | Payment of Exercise | 5,086 | $191.55 | $974,201.00 | (22%) 23.18K to 18.1K | |
| 05-Aug-22 4:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-22 | Grant | 11,311 | -- | -- | 95% 11.87K to 23.18K |